Information About 2,500 Camp Lejeune Injury Claims May Influence Settlement Process

Information About 2,500 Camp Lejeune Injury Claims May Influence Settlement Process

A federal judge has ordered lawyers to conduct a survey of 2,500 randomly selected Camp Lejeune injury lawsuits to help both plaintiffs and the U.S. government assess the scope of the litigation and promote settlement discussions that may resolve hundreds of thousands of claims brought over contaminated water at the U.S. Marine Corps training base in North Carolina.

The U.S. government faces nearly half a million administrative claims and lawsuits involving dozens of different injuries, all believed to be caused by exposure to toxic chemicals in water at Camp Lejeune between the mid-1950s and late 1980s.

The complaints were filed during a two-year window from August 2022 until August 2024 provided by the Camp Lejeune Justice Act (CLJA), which sought to provide financial compensation for individuals diagnosed with various types of cancer and other ailments after living, serving or working at the base. 

However, despite an elective settlement option for Camp Lejeune lawsuits announced in September 2023, very few claims have been resolved.

"*" indicates required fields

"*" indicates required fields

The litigation is being overseen by four different U.S. District Judges in the Eastern District of North Carolina, including Richard E. Myers II, Terrence W. Boyle, Louise W. Flanagan and James C. Dever III. To help gauge how the court may respond to certain evidence and testimony that will be presented throughout thousands of claims, the four judges are preparing groups of claims involving different categories of injuries for early trial dates.

However, according to a court order (PDF) issued on October 23, the judges hope those trials will not be necessary. They have announced that the court will select 2,500 random Camp Lejeune injury lawsuits whose attorneys and plaintiffs will be given questionnaires about various aspects of their claims.

Those completed questionnaires will be designed to give the parties and a Special Settlement Master an overview of the entire litigation and what a representative case looks like. The judges indicated they hope this information will help the parties reach a Camp Lejeune injury settlement agreement soon, seeking “expeditious pursuit of a substantial portion of the claims by year’s end.”

The court calls on every firm representing five or more claimants to provide status reports on the progress of the questionnaires and collection of supporting records throughout November, with all questionnaires and supporting records to be completed by November 24.

Camp Lejeune Injury Bellwether Lawsuits

If no settlement is reached in a timely fashion, the bellwether trial selection process will continue to proceed. The Court established a Camp Lejeune bellwether lawsuit Track 1 criteria in October 2023, in which the parties selected a group of 100 cases to go through early discovery involving the following five categories of injuries:

  • Bladder cancer
  • Kidney cancer
  • Leukemia
  • Parkinson’s disease
  • Non-Hodgkin’s lymphoma

The Court then directed the parties to narrow the list to 25 claims that will be eligible for trial, including five cases from each of the five injury categories, with plaintiffs selecting three of the claims and the U.S. government selecting the other two.

While the outcome of these early bellwether trials will not be binding on other claims in the litigation, they will be closely watched by lawyers involved in the cases, as the average amounts of any Camp Lejeune lawsuit payouts awarded may help the parties in global settlement negotiations for various types of injuries.


Written By: Irvin Jackson

Senior Legal Journalist & Contributing Editor

Irvin Jackson is a senior investigative reporter at AboutLawsuits.com with more than 30 years of experience covering mass tort litigation, environmental policy, and consumer safety. He previously served as Associate Editor at Inside the EPA and contributes original reporting on product liability lawsuits, regulatory failures, and nationwide litigation trends.




0 Comments


This field is for validation purposes and should be left unchanged.

Share Your Comments

This field is hidden when viewing the form
I authorize the above comments be posted on this page
Post Comment
Weekly Digest Opt-In

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

MORE TOP STORIES

Breast mesh products marketed as “internal bras” for lift and augmentation surgeries are now under investigation amid reports of painful complications, and questions over manufacturers’ prior knowledge of mesh-related risks.
A federal judge has set key scheduling deadlines for the four first bellwether trials over claims that BioZorb breast markers are defectively designed.
Parties in federal Depo-Provera meningioma lawsuits seek closer coordination with Delaware and New York state courts, proposing a synchronization of general causation schedules.